All-case Japanese post-marketing surveillance of the real-world safety and efficacy of rituximab treatment in patients with refractory nephrotic syndrome

por Kobayashi, Mana, Kageyama, Yutaro, Ando, Takashi, Sakamoto, Junko, Kimura, Shohji
Publicado 2021